Last reviewed · How we verify

NCT04123197: MIMS3

Mental Stress and Myocardial Ischemia After MI: Sex Differences, Mechanisms and Prognosis

Completed NA Last updated 12 August 2025
What this trial tests

NA trial testing Stress Challenge in Myocardial Infarction in 311 participants. Completed in 31 May 2025.

Timeline
28 February 2020
Primary endpoint
31 May 2025
31 May 2025

Quick facts

Lead sponsorEmory University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment311
Start date28 February 2020
Primary completion31 May 2025
Estimated completion31 May 2025
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Emory University

Who can join

Adults 18 to 60, any sex, with Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to look at the link between emotional stress and heart disease in men and women. Taking part in this study involves one clinic visit, one week of at home monitoring, and follow up phone calls every 6 months for 3 years.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Early Life Trauma Is Associated With Increased Microvolt T-Wave Alternans During Mental Stress Challenge: A Substudy of Mental Stress Ischemia: Prognosis and Genetic Influences.
    Shah AJ, Weeks V, Lampert R, Bremner JD, et al · · 2022 · cited 4× · PMID 35167312 · DOI 10.1161/jaha.121.021582

Verify or expand the search:

Other recruiting trials for Myocardial Infarction

Currently open trials in the same condition.

Other Emory University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04123197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing